Document is current
Any future updates will be listed below
-
Authors
Beilstein, Jakob https://orcid.org/0009-0007-7540-6151
Rich, David Q. https://orcid.org/0000-0001-7132-0069
Audebert, Heinrich J. https://orcid.org/0000-0002-4785-0366
Glatz, Toivo https://orcid.org/0000-0002-8994-7860
-
Funding
Funding for this research was provided by:
Charité - Universitätsmedizin Berlin
- License Information
-
More Information
Article History
Received: 24 November 2025
Accepted: 27 January 2026
First Online: 17 March 2026
Declarations
:
: Not applicable due to the sole use of secondary registry data.
: JB and DR report no disclosures relevant to the manuscript. HJA reports personal fees from Bayer Vital, Boehringer Ingelheim, Bristol-Myers Squibb, Novo Nordisk, Pfizer, Lilly and from Sanofi. TG has received a research grant from the Volkswagen Foundation unrelated to this work.
